Why did 4894.T stock drop so sharply today?

4894.T stock fell **33.97%** on 24 Feb 2026 amid heavy volume. The move reflects valuation concerns, negative EPS, and a weak company rating, combined with profit taking and a thin float that amplified selling pressure.

What are the key valuation metrics for 4894.T stock?

4894.T stock shows **EPS -81.54**, PE **-102.04**, PB **13.69**, and price-to-sales **192.85**. Cash per share is **JPY 460.62** and book value per share is **JPY 610.43**, highlighting mixed balance-sheet strength and high market valuation.

What price targets should investors use for 4894.T stock?

For 4894.T stock consider bear support **JPY 5,120.00**, conservative recovery **JPY 6,500.00**, and base-case target **JPY 10,200.00**. Use event-driven risk controls ahead of the **2026-05-20** earnings announcement.

How reliable is the Meyka AI forecast for 4894.T stock?

Meyka AI's forecast model projects **JPY 10,167.79** for the year, implying **40.60%** upside from **JPY 7,230.00**. Forecasts are model-based projections and not guarantees; they should supplement fundamental due diligence.

JP Stocks

4894.T stock down 33.97% to JPY 7,230.00 at JPX close 24 Feb 2026: key risk signals

ByDanny Kontos February 24, 2026

4894.T stock opened the JPX session on 24 Feb 2026 and closed down 33.97% at JPY 7,230.00 on heavy volume. The drop followed a gap from the previous close of JPY 10,950.00, with intraday range JPY 7,150.00 to JPY 7,900.00 and volume of 1,202,700.00 shares versus an average of 228,081.00. As a top loser on the Healthcare-biotechnology board, Cuorips Inc. (4894.T) shows stretched valuation metrics and volatile trading that require close monitoring for catalysts and downside protection.